Last update Dec. 4, 2020
Very Low Risk
We do not have alternatives for Oseltamivir Phosphate since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
Oseltamivir Phosphate in other languages or writings:
Oseltamivir Phosphate belongs to this group or family:
Main tradenames from several countries containing Oseltamivir Phosphate in its composition:
|Protein Binding||3 - 42||%|
|T½||6 - 10||hours|
|Ped.Relat.Dose||0.3 - 0.6||%|
Write us at email@example.com
e-lactancia is a resource recommended by Asociación Pro Lactancia Materna (APROLAM) of Mexico
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Inhibitor of the enzyme neuraminidase (sialidase), indicated in the treatment and prophylaxis of influenza.
Oral administration in two daily doses.
It is excreted in breastmilk in clinically insignificant amounts (Greer 2011, Wentges 2008), much lower than the dose used in newborns and infants (Greer 2011, Kanmaz 2011).
It has been used in newborns (Kanmaz 2010).
Various medical associations and expert consensus consider its use to be safe during breastfeeding (Dembinski 2010, Skalli 2010, Chen 2010, Tanaka 2009, ABM 2009, AEM 2009, Satpathy 2009).